Why GSK stock is moving today: Exdensur EU nod and a fresh buyback

GSK picked up roughly 1% on Wednesday, after the company announced European Commission approval for its Exdensur treatment—used for asthma and nasal polyps—and kicked off another round of share buybacks. Shares traded at 2,263 pence, up 1.1%.

18 February 2026

EU Regulations · LSE:GSK.L · Pharmaceuticals

CSL stock price ends higher after Eli Lilly clazakizumab deal, with buyback in the background

CSL Ltd jumped up to 2.1% on Wednesday after the Australian biotech signed a licensing agreement with Eli Lilly for clazakizumab, an investigational antibody currently in trials for end-stage kidney disease.

18 February 2026

ASX:CSL·Pharmaceuticals·Stock Market

Eli Lilly stock in focus as Retevmo lung cancer trial meets endpoint, with trading back Tuesday

Eli Lilly and Company turned in upbeat topline data from a pivotal trial of its cancer therapy Retevmo, teeing up a new challenge for the stock as U.S. markets get back to action Tuesday after the holiday.

16 February 2026

NYSE:LLY·Pharmaceuticals·Stock Market

Johnson & Johnson stock faces Tuesday test after fresh talc verdict as dividend date nears

Johnson & Johnson faces renewed pressure from talc lawsuits as the stock returns Tuesday, following a Pennsylvania jury’s verdict holding the company responsible in the most recent baby powder cancer case.

16 February 2026

Dividends·NYSE:JNJ·Pharmaceuticals·Stock Market

AbbVie stock ends higher Friday; what traders watch for ABBV after the Presidents Day break

AbbVie Inc finished Friday at $231.50, up 1.8%. The stock moved between $227.33 and $234.69 over the session.

15 February 2026

NYSE:ABBV·Pharmaceuticals·Stock Market

Healthcare stocks head into Presidents Day break after Dexcom, Moderna lift XLV

The Health Care Select Sector SPDR Fund ended Friday up about 1.1% at $157.67, as Dexcom jumped 7.6% and Moderna gained 5.3% after earnings updates.

15 February 2026

NASDAQ:DXCM·NASDAQ:MRNA·Pharmaceuticals

Eli Lilly stock price: $1.5 billion pill inventory puts April 10 FDA decision in spotlight

Eli Lilly and Company shares will be in the spotlight again when U.S. markets open Tuesday. The company revealed a $1.5 billion pre-launch inventory buildup for its oral weight-loss candidate, orforglipron. The stock last changed hands at $1,040.00, up roughly 0.2% from the previous finish. With markets closed Monday for Presidents Day, investors get one more day to process the update.

15 February 2026

NYSE:LLY·Pharmaceuticals·Stock Market

Vertex stock jumps nearly 6% on Oppenheimer upgrade as traders size up new drug pipeline

Shares of Vertex Pharmaceuticals Inc jumped 5.7% to close at $491.47 on Friday, pushing the Boston biotech into focus ahead of the holiday-shortened week. Oppenheimer’s Jay Olson gave the stock an upgrade to “Outperform” and set a $540 target.

14 February 2026

NASDAQ:VRTX·Pharmaceuticals·Stock Market

Eli Lilly stock: LLY closes at $1,040 as $1.5 billion pill stockpile comes into focus

Eli Lilly finished Friday at $1,040, ticking up roughly 0.3%. Traders reacted to a fresh filing indicating the company’s been stockpiling its experimental weight-loss pill. Source: https://www.barrons.com/market-data/stocks/lly

14 February 2026

NYSE:LLY·Pharmaceuticals·Stock Market

Moderna stock price jumps late after earnings beat, but FDA flu setback hangs over MRNA

Moderna jumped roughly 5% to $42.23 in late Friday trading. The vaccine maker managed to beat Wall Street’s revenue expectations and stuck with its 2026 growth targets, despite dealing with an FDA setback on its flu shot.

13 February 2026

Biotechnology·Earnings Reports·NASDAQ:MRNA·Pharmaceuticals·Stock Market

Merck stock pops on Deutsche Bank upgrade — what to watch ahead of ASCO GU

Merck & Co climbed 1.8% to $121.41 in Friday’s after-hours session, boosted by a Deutsche Bank upgrade to buy and a raised price target. Analyst James Shin argued, “We believe the market is currently undervaluing MRK … a clear path for MRK to navigate this transition.” Deutsche Bank projects that between the pipeline and recent acquisitions, Merck could tack on over $35 billion in risk-adjusted revenue by 2035.

13 February 2026

NYSE:MRK·Pharmaceuticals·Stock Market

Eli Lilly stock price climbs as $1.5 billion pill stockpile sharpens focus on FDA April decision

Eli Lilly and Company shares edged up 0.6% to $1,044.62 by midday, having traded between $1,034.69 and $1,063.68 earlier.

13 February 2026

NYSE:LLY·Pharmaceuticals·Stock Market

Eli Lilly stock climbs near 2%: China drug approval and GLP-1 pill race in focus

Eli Lilly and Company climbed almost 2% Thursday, pushing its rebound further as the company reported new regulatory progress for mirikizumab in China—a drug aimed at inflammatory bowel disease. By late morning, shares traded at $1,033.23, up 1.8%. The Health Care Select Sector SPDR Fund posted modest gains. Novo Nordisk’s U.S. shares, however, slipped.

12 February 2026

NYSE:LLY·Pharmaceuticals·Stock Market

GSK share price drops in early London trade as Arexvy China filing and insider sales set the tone

GSK slipped roughly 1.5% to 2,117 pence in early trading Thursday in London, pulling back after a robust run earlier this year. Shares had closed Wednesday at 2,153 pence.

12 February 2026

LSE:GSK.L·Pharmaceuticals·Stock Market

Pfizer stock slips before the open after a run to $27.73 — here’s what’s driving PFE now

Pfizer slipped 0.3% to $27.52 ahead of the bell Wednesday, following a 2.1% gain Tuesday that took shares to $27.61. The stock hit $27.73 during the session, with trading volume reaching roughly 43.6 million shares.

11 February 2026

NYSE:PFE·Pfizer·Pharmaceuticals·Stock Market

Hims & Hers stock steadies premarket after Novo Nordisk patent suit jolts weight-loss push

Hims & Hers Health stock edged 0.1% higher to $17.25 ahead of the open Wednesday, recovering a sliver after tumbling 10.8% Tuesday and sinking 16% the session before.

11 February 2026

NYSE:HIMS·NYSE:NVO·Pharmaceuticals·Stock Market

Phio Pharmaceuticals (PHIO) stock rises premarket as new PH-762 skin cancer data keeps traders circling

Shares of Phio Pharmaceuticals Corp jumped 9.8% to $1.23 ahead of the bell Wednesday, buoyed by new safety and response data for its main skin-cancer program. On Tuesday, the stock settled at $1.12, up 24.4%.

11 February 2026

NASDAQ:PHIO·Pharmaceuticals·Stock Market

AbbVie stock price rises as analysts reset targets and Wall Street waits on delayed jobs data

AbbVie Inc climbed 0.7% to $224.83 in early afternoon trading Tuesday, sticking near its session peak. Shares moved in a narrow band, fluctuating between $223.00 and $225.78.

10 February 2026

NYSE:ABBV·Pharmaceuticals·Stock Market

Merck stock price slips after insider sale filings; what MRK investors are watching next

Merck & Co fell 0.5% to $117.01 on Tuesday, slipping further as the market processed new insider trading filings. Shares swung from $116.10 up to $118.14.

10 February 2026

NYSE:MRK·Pharmaceuticals·Stock Market

Johnson & Johnson stock price today: JNJ flat as March conference talks and insider filing draw focus

Johnson & Johnson stock hovered near $238.70 in late morning Tuesday, showing little movement as investors took in a newly posted conference schedule and fresh insider transaction filings. Shares have traded between $237.89 and $240.52 during the session.

10 February 2026

NYSE:JNJ·Pharmaceuticals·Stock Market

Previous 1 … 12 13 14 15 16 … 49 Next

CSL stock price ends higher after Eli Lilly clazakizumab deal, with buyback in the background

Eli Lilly stock in focus as Retevmo lung cancer trial meets endpoint, with trading back Tuesday

Johnson & Johnson stock faces Tuesday test after fresh talc verdict as dividend date nears

AbbVie stock ends higher Friday; what traders watch for ABBV after the Presidents Day break

Healthcare stocks head into Presidents Day break after Dexcom, Moderna lift XLV

Eli Lilly stock price: $1.5 billion pill inventory puts April 10 FDA decision in spotlight

Vertex stock jumps nearly 6% on Oppenheimer upgrade as traders size up new drug pipeline

Eli Lilly stock: LLY closes at $1,040 as $1.5 billion pill stockpile comes into focus

Moderna stock price jumps late after earnings beat, but FDA flu setback hangs over MRNA

Merck stock pops on Deutsche Bank upgrade — what to watch ahead of ASCO GU

Eli Lilly stock price climbs as $1.5 billion pill stockpile sharpens focus on FDA April decision

Eli Lilly stock climbs near 2%: China drug approval and GLP-1 pill race in focus

GSK share price drops in early London trade as Arexvy China filing and insider sales set the tone

Pfizer stock slips before the open after a run to $27.73 — here’s what’s driving PFE now

Hims & Hers stock steadies premarket after Novo Nordisk patent suit jolts weight-loss push

Phio Pharmaceuticals (PHIO) stock rises premarket as new PH-762 skin cancer data keeps traders circling

AbbVie stock price rises as analysts reset targets and Wall Street waits on delayed jobs data

Merck stock price slips after insider sale filings; what MRK investors are watching next

Johnson & Johnson stock price today: JNJ flat as March conference talks and insider filing draw focus

TechStock² Updates

Fervo stock surges 24% with $1.1 billion market value boost after Google geothermal agreement

bioAffinity shares jump 45% on CyPath news, trading volume rises to 56 times share count

Nvidia Shares Slip 1.3%, Erasing $69 Billion as Rates Pressure AI Valuations

Nasdaq pares loss to 1.1% amid heavy trading as oil shock rattles markets

Nasdaq Falls Twice as Fast as S&P 500 as 10-Year Yield Hits 4.79%

AEye Shares Surge 26% After Lunar Lidar Agreement Overshadows Quarterly Turnover

UiPath Shares Trade 29% Over Analyst Price Target Ahead of Earnings

Medtronic Shares Climb 3.2% Following Upgraded Outlook and $700 Million Investment in Robotics

Ambev ADR Rises 0.7% as Brazilian Beer Sales Support Margin Outlook

Nasdaq Futures Drop 1.35% as Crude Surpasses $92 and Bond Yields Climb

Investment Disclaimer